D.E. Shaw & Co
CRGX

D.E. Shaw & Co’s CARGO Therapeutics CRGX Stock Holding History

D.E. Shaw & Co’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-783,553
Closed -$3.23M – 4611
2025
Q2 		$3.23M Buy
783,553
+737,899
+1,616% +$3.16M ﹤0.01% 2373
2025
Q1 		$186K Buy
+45,654
New +$306K ﹤0.01% 3944

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's CRGX Position: Q3 2025 in Review

D.E. Shaw & Co sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 783,553 shares — an estimated $3.23M sold.

D.E. Shaw & Co first reported a position in CRGX in Q1 2025 and held it in 2 quarters. The position peaked at $3.23M in Q2 2025. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • D.E. Shaw & Co reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 783,553 CARGO Therapeutics shares in Q3 2025, an estimated $3.23M.
  • D.E. Shaw & Co first reported a position in CARGO Therapeutics in Q1 2025 and held it in 2 quarters.
  • D.E. Shaw & Co's CARGO Therapeutics position peaked at $3.23M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.